Program overview

Print program
Thursday November 27, 2025Friday November 28, 2025

Closure

Closing remarks

Time: 15:45 - 16:00

Katrien Devreese, BSTH President

Paul Capel Prize – Clinical & Laboratory & Best Poster Award

Time: 15:30 - 15:45

State of the Art III – Diagnosis and treatment outside the comfort zone

Time: 14:30 - 15:30

Chairs: Thomas Vanassche & Phu Quoc Le

14:30-15:00 Antithrombotics management after venous stenting - Arina ten Cate
Netherlands
15:00-15:30 Bleeding Disorders of Unknown Causes - Ingrid Pabinger
Austria

Educational II

Time: 13:45 - 14:30

Chairs: Claudia Tersteeg & Cécile Oury

13:45 - 14:30 Platelet Physiology and Dysfunction - Kerstin Jurk
Germany

Lunch break and Poster walk

Time: 12:45 - 13:45

CSL Behring Encouragement Grant

Time: 12:30 - 12:45

Oral Presentations Basic Science

Time: 11:45 - 12:45

Chairs: Sandrine Horman & Cécile Oury

11:45 O01 Distinct open ADAMTS13 in acute and subclinical immune-mediated thrombotic thrombocytopenic purpura - Quintijn Bonnez
Belgium
11:57 O02 Targeting antigen-specific B cells in immune mediated thrombotic thrombocytopenic purpura using modular CAR T cells - Sara Rovira Puig
Belgium
12:09 O03 In vitro validation of the novel anti-CD19 and anti-CD38 UniCAR T cell therapy for refractory iTTP patients - Lisa Vermeersch
Belgium
12:21 O04 Enterococcus faecalis-induced infective endocarditis: first mechanistic insights and role of ticagrelor - Minoo Jafarzadeh
Belgium
12:33 O05 Mechanistic study of the antivirulence activity of ticagrelor at antiplatelet dosage - Florence Putters
Belgium

Coffee break

Time: 11:00 - 11:30

Sponsored Satellite Symposium III – Octapharma Benelux

Time: 10:00 - 11:00

Innovations in VWD and Unexplained Bleeding: Clinical Tools for Better Outcomes

  • Introduction by Prof. Peter Verhamme (KU Leuven)
  • Pharmacokinetic-Guided Dosing to Personalize Prophylaxis in von Willebrand Disease, Prof. Ron Mathôt (AUMC Amsterdam)
  • Introduction by Prof. Peter Verhamme (KU Leuven)
  • Bleeding Disorder of Unknown Cause: current insights and future directions, Dr. Floor Moenen (MUMC Maastricht)
  • Q&A

Registration, Coffee & Networking

Time: 08:30 - 09:00

Dinner

Time: 19:00 - 19:00

Hotel Van der Valk Mechelen, Rode Kruisplein 1-4, Mechelen

Cold and warm buffet followed by a small party with a DJ to celebrate together!

Closure

Time: 17:45 - 17:45

Paul Capel Prize – Basic Science

Time: 17:30 - 17:45

Professor Gaston Baele Memorial Lecture

Time: 16:45 - 17:30

Chair: Katrien Devreese

From Thrombosis to Thrombin: A Journey of Mentorship, Memory, and Meaning - Anne Demulder

Coffee break

Time: 16:15 - 16:45

Sponsored Satellite Symposium II – Pfizer

Time: 15:15 - 16:15

Rebalancing hemostasis with anti-TFPI treatments

  • Dr Quentin Van Thillo
  • Dr Susan Halimeh

State of the Art I – Antithrombotics in special situations

Time: 14:15 - 15:15

Chairs: Peter Verhamme & Laurence Rozen

14:15-14:45 Thrombosis and antithrombotics needs in bleeding disorders - Roger Schutgens
Netherlands
14:45-15:15 Antithrombotics management after TAVI - Patrizio Lancellotti
Belgium

BSTH General Assembly

Time: 13:45 - 14:15

Exclusively for members

Sponsored Satellite Symposium I – Novo Nordisk

Time: 10:15 - 11:15

Transforming Conversations: Evolving Hemophilia Treatment and Its Influence on Patient–Physician Shared Decision-Making

  • Prof. Cedric Hermans

Welcome

Time: 09:15 - 09:28

Katrien Devreese, BSTH President

State of the Art II – Thrombosis and beyond

Time: 09:00 - 10:00

Chairs: Simon De Meyer & Quintijn Bonnez

09:00-09:30 Complement-mediated thrombosis - Christoph Schmidt
Germany
09:30-10:00 Antibodies and complement as key drivers of thrombosis - Konstantin Stark
Germany

Oral presentations Clinical and Laboratory

Time: 11:30 - 12:30

Chairs: Jan Emmerechts & Christelle Orlando

11:30 O06 Venous Thromboembolism in Women on Estrogen Therapy: Presentation, Management, and Outcomes in the RIETE Registry. - Andreas Verstraete
Belgium
11:42 O07 Population-scale proteomics identify new risk markers for venous thromboembolism - Art Schuermans
Belgium
11:54 O08 Longitudinal Changes in Thrombin Generation Before and After Haemodialysis Initiation in Patients with End-Stage Kidney Disease - Eline Hoes
Belgium
12:06 O09 Assay performance in measuring efanesoctocog alfa activity: The impact of calibrator selection on one-stage clotting and chromogenic FVIII assays - Mohammad Amir
Belgium
12:18 O10 Agreement between anti-factor Xa and aPTT in recipients of long term left ventricular assist devices: which is the better predictor of long-term survival? - Christophe Vandenbriele
Belgium

Lunch break and Poster walk

Time: 12:45 - 13:45

Coffee break

Time: 11:15 - 11:45

Educational I

Time: 09:30 - 10:15

Chairs: Kristel Vandebosch & Séverine De Bruijn

09:30 - 10:15 New therapies and monitoring in von Willebrand disease - Jeroen Eikenboom
Netherlands

Registration, Coffee, Networking

Time: 08:30 - 09:15
Home › Program
Website and marketing